Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Steglatro
(ertugliflozin)
Uses, side effects, dosage information & price range
About this medicine
Steglatro is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control: as monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications. in addition to other medicinal products for the treatment of diabetes.
Common Brand Names for this Composition
The following popular commercial brand names contain ertugliflozin as their active ingredient composition:
Steglatro
Merck Sharp & Dohme B.V.
Steglujan
Merck Sharp & Dohme B.V.
Segluromet
Merck Sharp & Dohme B.V.
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
ertugliflozin
Category
Drugs used in diabetes;Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Manufacturer
Merck Sharp & Dohme B.V.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.